Cancer Biology

1302 Dendritic cells direct circadian anti-tumour immune responses.

1301 PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.

1300 An Integrated Polymeric mRNA Vaccine without Inflammation Side Effects for Cellular Immunity Mediated Cancer Therapy.

1299 Autonomous rhythmic activity in glioma networks drives brain tumour growth.

1298 Ferritin-Hijacking Nanoparticles Spatiotemporally Directing Endogenous Ferroptosis for Synergistic Anticancer Therapy.

1297 Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2.

1296 Ferroptosis of tumour neutrophils causes immune suppression in cancer.

1295 Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.

1294 Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.

1293 A poor prognosis gene programme in patients with colorectal cancer is expressed by a unique tumour cell population that we name high-relapse cells (HRCs), and ablation of cells expressing the HRC marker EMP1 or neoadjuvant immunotherapy prevented metastatic recurrence in animal models.

1292 Nociceptor neurons affect cancer immunosurveillance.

1291 Magnetosome-inspired synthesis of soft ferrimagnetic nanoparticles for magnetic tumor targeting.

1290 Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice.

1289 Escape from breast tumor dormancy: The convergence of obesity and menopause.

1288 A flexible electronic strain sensor for the real-time monitoring of tumor regression.

1287 A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors.

1286 Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions.

1285 Brown-fat-mediated tumour suppression by cold-altered global metabolism.

1284 Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy.

1283 In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.

Free Images for Presentation: sunipix SUNIPIX